Mollie Condra, Ph.D.
Investor Relations &
HealthStream, Inc. (Nasdaq: HSTM), a leading healthcare technology platform for workforce solutions, announced today that it will hold a conference call and webcast to discuss its fourth quarter & full-year 2023 financial results on Tuesday, February 20th, 2024. The Company’s financial results for the fourth quarter and full-year ended December 31st, 2023 will be released after the routine time for the close of the market on Monday, February 19th, 2024.
HealthStream’s fourth quarter & full-year 2023 earnings conference call will begin at 9:00 a.m. Eastern Time on Tuesday, February 20th, 2024. Participants may access the conference call live via webcast using this link: Webcast Link Here. To participate via telephone, please register in advance using this LINK. Upon registration, all telephone participants will receive a one-time confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. All participants are instructed to dial-in 15 minutes prior to the start time. A replay of the conference call and webcast will be archived on the Company's website for at least 30 days.
HealthStream (Nasdaq: HSTM) is the healthcare industry’s largest ecosystem of platform-delivered workforce solutions that empowers healthcare professionals to do what they do best: deliver excellence in patient care. For more information, visit http://www.healthstream.com or call 800-521-0574.
This press release contains forward-looking statements that involve risks and uncertainties regarding HealthStream. This information has been included in reliance on the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such results or events predicted in these statements may differ materially from actual future events or results. These forward-looking statements are based on a variety of assumptions that may not be realized, and which are subject to significant risks and uncertainties, including that the anticipated financial and strategic benefits of the acquisition may not be realized, as well as risks and uncertainties referenced from time to time in the Company’s filings with the Securities and Exchange Commission.